Strata Critical Medical, Inc. Class A Common Stock (SRTA) is a publicly traded the market company. As of May 21, 2026, SRTA trades at $5.41 with a market cap of $464.65M and a P/E ratio of 11.01. SRTA moved +6.13% today. Year to date, SRTA is -1.77%; over the trailing twelve months it is flat. Its 52-week range spans $3.85 to $6.02. Analyst consensus is strong buy with an average price target of $9.17. Rallies surfaces SRTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Strata Critical Medical’s Public and Private Warrants Expire at 5 PM ET: Strata Critical Medical’s Public Warrants and Private Placement Warrants expired as scheduled at 5:00 PM Eastern Time on May 7, 2026, removing further potential share dilution under their original terms. The lapse of these instruments ends any prospect of exercise proceeds, leaving Strata’s capital structure unchanged beyond existing equity.
| Metric | Value |
|---|---|
| Price | $5.41 |
| Market Cap | $464.65M |
| P/E Ratio | 11.01 |
| EPS | $0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.02 |
| 52-Week Low | $3.85 |
| Volume | 737.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $197.14M |
| Net Income | $41.35M |
| Gross Margin | 20.86% |
4 analysts cover SRTA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.17.